The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 290.5% in November

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 41,000 shares, an increase of 290.5% from the October 31st total of 10,500 shares. Based on an average trading volume of 26,100 shares, the short-interest ratio is presently 1.6 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Up 1.8 %

Shares of NASDAQ:CGABL traded up $0.35 during midday trading on Friday, hitting $19.60. The stock had a trading volume of 49,642 shares, compared to its average volume of 22,206. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 1 year low of $17.49 and a 1 year high of $20.85. The stock has a 50 day moving average price of $19.81 and a two-hundred day moving average price of $19.04.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, November 15th. Investors of record on Saturday, November 1st will be issued a dividend of $0.2891 per share. This represents a $1.16 dividend on an annualized basis and a yield of 5.90%. The ex-dividend date of this dividend is Friday, October 31st.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.